Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: Relevance to multiple sclerosis pathogenesis

Brain

Volumn 134, Issue 2, 2011, Pages 555-570

  Kooij, Gijs ^a   Mizee, Mark R ^a   Van Horssen, Jack ^a   Reijerkerk, Arie ^a   Witte, Maarten E ^a   Drexhage, Joost A R ^a   Van Der Pol, Susanne M A ^a   Van Het Hof, Bert ^a   Scheffer, George ^a   Scheper, Rik ^a   Dijkstra, Christine D ^a   Van Der Valk, Paul ^a   De Vries, Helga E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

adenosine triphosphate binding cassette transporter; astrocytes; blood brain barrier; chemokine (C C motif) ligand 2; multiple sclerosis

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CHEMOKINE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; TOLL LIKE RECEPTOR 3;

ADULT; AGED; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL ACTIVATION; CELL CULTURE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MALE; MEDIATOR; MULTIPLE SCLEROSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; BRAIN; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CHEMOKINE CCL2; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS;

EID: 79551692740     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq330     Document Type: Article

References (61)

1. Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Leenstra S, et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 2003; 118: 417-29. (Pubitemid 36423257)
2. Bauer B, Hartz AM, Miller DS. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 2007; 71: 667-75. (Pubitemid 46294078)
3. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537-92. (Pubitemid 34800230)
4. Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006; 129: 517-26. (Pubitemid 43164373)
5. Bruck W, Sommermeier N, Bergmann M, Zettl U, Goebel HH, Kretzschmar HA, et al. Macrophages in multiple sclerosis. Immunobiology 1996; 195: 588-600. (Pubitemid 26361485)
6. Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 2006; 25: 231-59. (Pubitemid 44034685)
7. De Groot CJ, Langeveld CH, Jongenelen CA, Montagne L, van der Valk P, Dijkstra CD. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J Neurosci Res 1997; 49: 342-54. (Pubitemid 27344194)
8. Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, et al. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 1996; 88: 1747-54. (Pubitemid 26307071)
9. Elkord E, Williams PE, Kynaston H, Rowbottom AW. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 2005; 114: 204-12. (Pubitemid 40208937)
10. Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol 1994; 4: 229-37. (Pubitemid 24261929)
11. Ernest S, Bello-Reuss E. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. J Am Soc Nephrol 1999; 10: 2306-13. (Pubitemid 29501463)
12. Ewing C, Bernard CC. Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998; 76: 47-54. (Pubitemid 28194697)
13. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 2000; 192: 899-905.
14. Frank MH, Denton MD, Alexander SI, Khoury SJ, Sayegh MH, Briscoe DM. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J Immunol 2001; 166: 2451-9. (Pubitemid 32173481)
15. Frevert CW, Wong VA, Goodman RB, Goodwin R, Martin TR. Rapid fluorescence-based measurement of neutrophil migration in vitro. J Immunol Methods 1998; 213: 41-52. (Pubitemid 28376594)
16. Frohman EM, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006; 354: 942-55.
17. Garcia-Vallejo JJ, Van Het HB, Robben J, Van Wijk JA, Van Die I, Joziasse DH, et al. Approach for defining endogenous reference genes in gene expression experiments. Anal Biochem 2004; 329: 293-9. (Pubitemid 38680512)
18. Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 2003; 139: 35-48. (Pubitemid 36645306)
19. Huang YH, Schafer-Elinder L, Wu R, Claesson HE, Frostegard J. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol 1999; 116: 326-31. (Pubitemid 29219732)
20. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000; 192: 1075-80.
21. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SM, et al. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One 2009; 4: e8212.
22. Kooij G, van Horssen J, de Lange EC, Reijerkerk A, van der Pol SM, van het Hof B, et al. T lymphocytes impair P-glycoprotein function during neuroinflammation. J Autoimmun 2010; 34: 416-25.
23. Koubeissi A, Raad I, Ettouati L, Guilet D, Dumontet C, Paris J. Inhibition of P-glycoprotein-mediated multidrug efflux by aminomethylene and ketomethylene analogs of reversins. Bioorg Med Chem Lett 2006; 16: 5700-3. (Pubitemid 44415428)
24. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 2006; 46: 381-410. (Pubitemid 43271195)
25. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001; 7: 115-21. (Pubitemid 32201673)
26. Li H, Cuzner ML, Newcombe J. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol 1996; 22: 207-15. (Pubitemid 26177449)
27. Loscher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2005a; 2: 86-98. (Pubitemid 40128029)
28. Loscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005b; 6: 591-602. (Pubitemid 41059334)
29. Lucchinetti C, Bruck W, Noseworthy J. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 2001; 14: 259-69. (Pubitemid 32510588)
30. Marroni M, Agrawal ML, Kight K, Hallene KL, Hossain M, Cucullo L, et al. Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytes. Neuroscience 2003; 121: 605-17. (Pubitemid 38367500)
31. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998; 139: 1789-93. (Pubitemid 28513838)
32. Nies AT, Jedlitschky G, Konig J, Herold-Mende C, Steiner HH, Schmitt HP, et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004; 129: 349-60. (Pubitemid 39388854)
33. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, et al. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem 2008; 105: 2249-59. (Pubitemid 351782279)
34. Oerlemans R, van der HJ, Vink J, Dijkmans BA, Kaspers GJ, Lems WF, et al. Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids. Arthritis Rheum 2006; 54: 557-68. (Pubitemid 43228632)
35. Out R, Jessup W, Le GW, Hoekstra M, Gelissen IC, Zhao Y, et al. Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. Circ Res 2008; 102: 113-20.
36. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427-34. (Pubitemid 40780846)
37. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006; 354: 899-910.
38. Potschka H, Fedrowitz M, Loscher W. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepi-leptic drug activity. J Pharmacol Exp Ther 2003; 306: 124-31. (Pubitemid 36734365)
39. Raggers RJ, Vogels I, van MG. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem J 2001; 357: 859-65.
40. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999; 96: 3900-5. (Pubitemid 29169008)
41. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20: 570-7. (Pubitemid 27508969)
42. Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 2002; 125: 22-31. (Pubitemid 34084034)
43. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009; 32: 638-47.
44. Speth C, Dierich MP, Sopper S. HIV-infection of the central nervous system: the tightrope walk of innate immunity. Mol Immunol 2005; 42: 213-28. (Pubitemid 39361450)
45. Sukhai M, Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci 2000; 3: 268-80.
46. Tani M, Glabinski AR, Tuohy VK, Stoler MH, Estes ML, Ransohoff RM. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 1996; 148: 889-96. (Pubitemid 126660680)
47. Tani M, Ransohoff RM. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathol 1994; 4: 135-43.
48. Tekstra J, Visser CE, Tuk CW, Brouwer-Steenbergen JJ, Burger CW, Krediet RT, et al. Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2379-84. (Pubitemid 27465942)
49. van de Ven R, de Jong MC, Reurs AW, Schoonderwoerd AJ, Jansen G, Hooijberg JH, et al. Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J Immunol 2006; 176: 5191-8.
50. van de Ven R, Scheffer GL, Scheper RJ, de Gruijl TD. The ABC of dendritic cell development and function. Trends Immunol 2009; 30: 421-9.
51. Van der Goes A, Boorsma W, Hoekstra K, Montagne L, De Groot CJ, Dijkstra CD. Determination of the sequential degradation of myelin proteins by macrophages. J Neuroimmunol 2005; 161: 12-20. (Pubitemid 40347246)
52. van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, et al. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis Rheum 2009; 60: 669-77.
53. van der Pol MA, Feller N, Ossenkoppele GJ, Weijers GW, Westra AH, van Stijn A, et al. Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis. Leukemia 2003; 17: 1674-7. (Pubitemid 36986975)
54. van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000; 26: 2-10. (Pubitemid 30145301)
55. van der Voorn P, Tekstra J, Beelen RH, Tensen CP, van der Valk P, De Groot CJ. Expression of MCP-1 by reactive astrocytes in demyeli-nating multiple sclerosis lesions. Am J Pathol 1999; 154: 45-51. (Pubitemid 29031610)
56. van Horssen J, Bo L, Dijkstra CD, de Vries HE. Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol Dis 2006a; 24: 484-91. (Pubitemid 44716678)
57. van Horssen J, Vos CM, Admiraal L, van Haastert ES, Montagne L, van der Valk P, et al. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions. Neuropathol Appl Neurobiol 2006b; 32: 585-93. (Pubitemid 44684644)
58. Viegas P, Chaverot N, Enslen H, Perriere N, Couraud PO, Cazaubon S. Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci 2006; 119: 4634-43. (Pubitemid 44964260)
59. Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, et al. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PLoS One 2010; 5: e10456.
60. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005; 19: 1872-4. (Pubitemid 41598779)
61. Zhu HJ, Liu GQ. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sci 2004; 75: 1313-22.